{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:10:57Z","timestamp":1784304657314,"version":"3.55.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03148-0","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T09:01:42Z","timestamp":1718442102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Treatment of calcinosis cutis associated with autoimmune connective tissue diseases"],"prefix":"10.1007","volume":"316","author":[{"given":"Charles B.","family":"Lau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon P.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"issue":"2","key":"3148_CR1","first-page":"55","volume":"52","author":"A Dima","year":"2014","unstructured":"Dima A, Balanescu P, Baicus C (2014) Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases. Rom J Intern Med 52(2):55\u201367","journal-title":"Rom J Intern Med"},{"issue":"1","key":"3148_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2010.08.038","volume":"65","author":"N Reiter","year":"2011","unstructured":"Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E (2011) Calcinosis cutis: part I. Diagnostic pathway. J Am Acad Dermatol 65(1):1\u201312 quiz 13\u201314. https:\/\/doi.org\/10.1016\/j.jaad.2010.08.038","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"3148_CR3","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.adengl.2015.10.018","volume":"106","author":"D Jim\u00e9nez-Gallo","year":"2015","unstructured":"Jim\u00e9nez-Gallo D, Ossorio-Garc\u00eda L, Linares-Barrios M (2015) Calcinosis Cutis and Calciphylaxis. Actas Dermo-Sifiliogr\u00e1ficas (English Edition) 106(10):785\u2013794. https:\/\/doi.org\/10.1016\/j.adengl.2015.10.018","journal-title":"Actas Dermo-Sifiliogr\u00e1ficas (English Edition)"},{"issue":"6","key":"3148_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.semarthrit.2005.01.016","volume":"34","author":"N Boulman","year":"2005","unstructured":"Boulman N, Slobodin G, Rozenbaum M, Rosner I (2005) Calcinosis in Rheumatic diseases. Semin Arthritis Rheum 34(6):805\u2013812. https:\/\/doi.org\/10.1016\/j.semarthrit.2005.01.016","journal-title":"Semin Arthritis Rheum"},{"key":"3148_CR5","doi-asserted-by":"publisher","first-page":"701603","DOI":"10.4061\/2011\/701603","volume":"2011","author":"SK Goel","year":"2011","unstructured":"Goel SK, Bellovich K, McCullough PA (2011) Treatment of severe metastatic calcification and Calciphylaxis in Dialysis patients. Int J Nephrol 2011:701603. https:\/\/doi.org\/10.4061\/2011\/701603","journal-title":"Int J Nephrol"},{"issue":"3","key":"3148_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.0303-6987.2004.00169.x","volume":"31","author":"LC Edsall","year":"2004","unstructured":"Edsall LC, English JC III, Patterson JW (2004) Calciphylaxis and metastatic calcification associated with nephrogenic fibrosing dermopathy. J Cutan Pathol 31(3):247\u2013253. https:\/\/doi.org\/10.1111\/j.0303-6987.2004.00169.x","journal-title":"J Cutan Pathol"},{"issue":"4","key":"3148_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1067\/mjd.2002.122196","volume":"47","author":"RE Fisler","year":"2002","unstructured":"Fisler RE, Liang MG, Fuhlbrigge RC, Yalcindag A, Sundel RP (2002) Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis. J Am Acad Dermatol 47(4):505\u2013511. https:\/\/doi.org\/10.1067\/mjd.2002.122196","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3148_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/23971983211053245","volume":"7","author":"A Valenzuela","year":"2022","unstructured":"Valenzuela A, Chung L (2022) Subcutaneous calcinosis: is it different between systemic sclerosis and dermatomyositis? J Scleroderma Relat Disord 7(1):7\u201323. https:\/\/doi.org\/10.1177\/23971983211053245","journal-title":"J Scleroderma Relat Disord"},{"issue":"4","key":"3148_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","volume":"148","author":"SJ Balin","year":"2012","unstructured":"Balin SJ, Wetter DA, Andersen LK, Davis MDP (2012) Calcinosis Cutis Occurring in Association with Autoimmune connective tissue disease: the Mayo Clinic Experience with 78 patients, 1996\u20132009. Arch Dermatol 148(4):455\u2013462. https:\/\/doi.org\/10.1001\/archdermatol.2011.2052","journal-title":"Arch Dermatol"},{"issue":"5","key":"3148_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.semarthrit.2020.06.007","volume":"50","author":"A Valenzuela","year":"2020","unstructured":"Valenzuela A, Baron M, Rodriguez-Reyna TS et al (2020) Calcinosis is associated with ischemic manifestations and increased disability in patients with systemic sclerosis. Semin Arthritis Rheum 50(5):891\u2013896. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.007","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"3148_CR11","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/acr.22672","volume":"68","author":"L Morardet","year":"2016","unstructured":"Morardet L, Avouac J, Sammour M et al (2016) Late Nailfold Videocapillaroscopy Pattern Associated with Hand Calcinosis and Acro-Osteolysis in systemic sclerosis. Arthritis Care Res 68(3):366\u2013373. https:\/\/doi.org\/10.1002\/acr.22672","journal-title":"Arthritis Care Res"},{"issue":"27","key":"3148_CR12","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM et al (1993) A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 329(27):1993\u20132000. https:\/\/doi.org\/10.1056\/NEJM199312303292704","journal-title":"N Engl J Med"},{"issue":"6 Suppl","key":"3148_CR13","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/1097-0142(19910915)68:6+<1430::aid-cncr2820681405>3.0.co;2-4","volume":"68","author":"M Ballow","year":"1991","unstructured":"Ballow M (1991) Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases. Cancer 68(6 Suppl):1430\u20131436. https:\/\/doi.org\/10.1002\/1097-0142(19910915)68:6+<1430::aid-cncr2820681405>3.0.co;2-4","journal-title":"Cancer"},{"issue":"1","key":"3148_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1756-185X.2008.00336.x","volume":"11","author":"MC Yang","year":"2008","unstructured":"Yang MC, Lee JH, Yang YH, Chiang BL (2008) Improvement of juvenile dermatomyositis with calcinosis universalis after treatment with intravenous immunoglobulin. Int J Rheum Dis 11(1):77\u201380. https:\/\/doi.org\/10.1111\/j.1756-185X.2008.00336.x","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"3148_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/archderm.144.5.585","volume":"144","author":"S Schanz","year":"2008","unstructured":"Schanz S, Ulmer A, Fierlbeck G (2008) Response of Dystrophic calcification to Intravenous Immunoglobulin. Arch Dermatol 144(5):585\u2013587. https:\/\/doi.org\/10.1001\/archderm.144.5.585","journal-title":"Arch Dermatol"},{"issue":"6","key":"3148_CR16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jaad.2008.09.051","volume":"60","author":"Y Pe\u00f1ate","year":"2009","unstructured":"Pe\u00f1ate Y, Guillermo N, Melwani P, Martel R, Hern\u00e1ndez-Mach\u00edn B, Borrego L (2009) Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin. J Am Acad Dermatol 60(6):1076\u20131077. https:\/\/doi.org\/10.1016\/j.jaad.2008.09.051","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3148_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaad.2015.03.047","volume":"73","author":"F Galimberti","year":"2015","unstructured":"Galimberti F, Li Y, Fernandez AP (2015) Intravenous immunoglobulin for treatment of dermatomyositis-associated dystrophic calcinosis. J Am Acad Dermatol 73(1):174\u2013176. https:\/\/doi.org\/10.1016\/j.jaad.2015.03.047","journal-title":"J Am Acad Dermatol"},{"key":"3148_CR18","doi-asserted-by":"publisher","first-page":"bcr2012006629","DOI":"10.1136\/bcr-2012-006629","volume":"2012","author":"L Shahani","year":"2012","unstructured":"Shahani L (2012) Refractory calcinosis in a patient with dermatomyositis: response to intravenous immune globulin. Case Rep 2012:bcr2012006629. https:\/\/doi.org\/10.1136\/bcr-2012-006629","journal-title":"Case Rep"},{"issue":"3","key":"3148_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archdermatol.2008.620","volume":"145","author":"AH Kalajian","year":"2009","unstructured":"Kalajian AH, Perryman JH, Callen JP (2009) Intravenous immunoglobulin therapy for Dystrophic Calcinosis Cutis: unreliable in our hands. Arch Dermatol 145(3):334. https:\/\/doi.org\/10.1001\/archdermatol.2008.620","journal-title":"Arch Dermatol"},{"issue":"2","key":"3148_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10067-012-2124-z","volume":"32","author":"DR de Paula","year":"2013","unstructured":"de Paula DR, Klem FB, Lorencetti PG, Muller C, Azevedo VF (2013) Rituximab-induced regression of CREST-related calcinosis. Clin Rheumatol 32(2):281\u2013283. https:\/\/doi.org\/10.1007\/s10067-012-2124-z","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3148_CR21","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.semarthrit.2011.11.007","volume":"41","author":"D Daoussis","year":"2012","unstructured":"Daoussis D, Antonopoulos I, Liossis SNC, Yiannopoulos G, Andonopoulos AP (2012) Treatment of systemic sclerosis-Associated calcinosis: a Case Report of Rituximab-Induced regression of CREST-Related calcinosis and review of the literature. Semin Arthritis Rheum 41(6):822\u2013829. https:\/\/doi.org\/10.1016\/j.semarthrit.2011.11.007","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"3148_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.autrev.2018.10.006","volume":"18","author":"J Narv\u00e1ez","year":"2019","unstructured":"Narv\u00e1ez J, Pirola JP, LLuch J, Juarez P, Nolla JM, Valenzuela A (2019) Effectiveness and safety of Rituximab for the treatment of refractory systemic sclerosis associated calcinosis: a case series and systematic review of the literature. Autoimmun rev 18(3):262\u2013269. https:\/\/doi.org\/10.1016\/j.autrev.2018.10.006","journal-title":"Autoimmun rev"},{"issue":"7","key":"3148_CR23","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.3899\/jrheum.101321","volume":"38","author":"B Bader-Meunier","year":"2011","unstructured":"Bader-Meunier B, Decaluwe H, Barnerias C et al (2011) Safety and Efficacy of Rituximab in severe Juvenile Dermatomyositis: results from 9 patients from the French autoimmunity and Rituximab Registry. J Rhuematol 38(7):1436\u20131440. https:\/\/doi.org\/10.3899\/jrheum.101321","journal-title":"J Rhuematol"},{"key":"3148_CR24","doi-asserted-by":"publisher","first-page":"bcr2015213179","DOI":"10.1136\/bcr-2015-213179","volume":"2016","author":"M Dubos","year":"2016","unstructured":"Dubos M, Ly K, Martel C, Fauchais AL (2016) Is rituximab an effective treatment of refractory calcinosis? Case Rep 2016:bcr2015213179. https:\/\/doi.org\/10.1136\/bcr-2015-213179","journal-title":"Case Rep"},{"issue":"4","key":"3148_CR25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/cc11304","volume":"16","author":"PM Kasi","year":"2012","unstructured":"Kasi PM, Tawbi HA, Oddis CV, Kulkarni HS (2012) Clinical review: serious adverse events associated with the use of rituximab - a critical care perspective. Crit Care 16(4):231. https:\/\/doi.org\/10.1186\/cc11304","journal-title":"Crit Care"},{"issue":"1","key":"3148_CR26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13075-020-02164-5","volume":"22","author":"R Campanilho-Marques","year":"2020","unstructured":"Campanilho-Marques R, Deakin CT, Simou S et al (2020) Retrospective analysis of infliximab and adalimumab treatment in a large cohort of juvenile dermatomyositis patients. Arthritis Res Therapy 22(1):79. https:\/\/doi.org\/10.1186\/s13075-020-02164-5","journal-title":"Arthritis Res Therapy"},{"issue":"12","key":"3148_CR27","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s11926-014-0467-y","volume":"16","author":"MF Hoeltzel","year":"2014","unstructured":"Hoeltzel MF, Oberle EJ, Robinson AB, Agarwal A, Rider LG (2014) The Presentation, Assessment, Pathogenesis, and treatment of Calcinosis in Juvenile Dermatomyositis. Curr Rheumatol Rep 16(12):467. https:\/\/doi.org\/10.1007\/s11926-014-0467-y","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"3148_CR28","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","volume":"43","author":"LM Pachman","year":"2000","unstructured":"Pachman LM, Liotta-Davis MR, Hong DK et al (2000) TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 43(10):2368\u20132377. https:\/\/doi.org\/10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","journal-title":"Arthritis Rheum"},{"issue":"6","key":"3148_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","volume":"47","author":"P Riley","year":"2008","unstructured":"Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA (2008) Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis. Rheumatology 47(6):877\u2013880. https:\/\/doi.org\/10.1093\/rheumatology\/ken074","journal-title":"Rheumatology"},{"issue":"5","key":"3148_CR30","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/rheumatology\/ket365","volume":"53","author":"S Tosounidou","year":"2014","unstructured":"Tosounidou S, MacDonald H, Situnayake D (2014) Successful treatment of calcinosis with infliximab in a patient with systemic sclerosis\/myositis overlap syndrome. Rheumatology 53(5):960\u2013961. https:\/\/doi.org\/10.1093\/rheumatology\/ket365","journal-title":"Rheumatology"},{"key":"3148_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jaut.2019.03.003","volume":"100","author":"S Wendel","year":"2019","unstructured":"Wendel S, Venhoff N, Frye BC et al (2019) Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-kinase inhibitor tofacitinib \u2013 A report of two cases. J Autoimmun 100:131\u2013136. https:\/\/doi.org\/10.1016\/j.jaut.2019.03.003","journal-title":"J Autoimmun"},{"issue":"11","key":"3148_CR32","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.1093\/rheumatology\/keab421","volume":"60","author":"M Shneyderman","year":"2021","unstructured":"Shneyderman M, Ahlawat S, Christopher-Stine L, Paik JJ (2021) Calcinosis in refractory dermatomyositis improves with tofacitinib monotherapy: a case series. Rheumatology (Oxford) 60(11):e387\u2013e388. https:\/\/doi.org\/10.1093\/rheumatology\/keab421","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"3148_CR33","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1093\/rheumatology\/keaa360","volume":"59","author":"B S\u00f6zeri","year":"2020","unstructured":"S\u00f6zeri B, Demir F (2020) A striking treatment option for recalcitrant calcinosis in juvenile dermatomyositis: tofacitinib citrate. Rheumatology 59(12):e140\u2013e141. https:\/\/doi.org\/10.1093\/rheumatology\/keaa360","journal-title":"Rheumatology"},{"issue":"3","key":"3148_CR34","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jpeds.2011.11.057","volume":"160","author":"B Arabshahi","year":"2012","unstructured":"Arabshahi B, Silverman RA, Jones OY, Rider LG (2012) Abatacept and Sodium Thiosulfate for treatment of recalcitrant juvenile Dermatomyositis complicated by Ulceration and Calcinosis. J Pediatr 160(3):520\u2013522. https:\/\/doi.org\/10.1016\/j.jpeds.2011.11.057","journal-title":"J Pediatr"},{"key":"3148_CR35","doi-asserted-by":"publisher","first-page":"e4073879","DOI":"10.1155\/2020\/4073879","volume":"2020","author":"S Sukumaran","year":"2020","unstructured":"Sukumaran S, Vijayan V (2020) Abatacept in the treatment of Juvenile Dermatomyositis-Associated calcifications in a 16-Year-old girl. Case Rep Rheumatol 2020:e4073879. https:\/\/doi.org\/10.1155\/2020\/4073879","journal-title":"Case Rep Rheumatol"},{"key":"3148_CR36","doi-asserted-by":"publisher","unstructured":"Gorrepati PL, Smith GP (2022) Treatments for calcinosis cutis in autoimmune connective tissue diseases. J Am Acad Dermatol 0(0). https:\/\/doi.org\/10.1016\/j.jaad.2022.03.029","DOI":"10.1016\/j.jaad.2022.03.029"},{"issue":"4","key":"3148_CR37","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1046\/j.1365-2133.2001.04153.x","volume":"144","author":"Y Ichiki","year":"2001","unstructured":"Ichiki Y, Akiyama T, Shimozawa N, Suzuki Y, Kondo N, Kitajima Y (2001) An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol 144(4):894\u2013897. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04153.x","journal-title":"Br J Dermatol"},{"issue":"1","key":"3148_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-4632.2009.04449.x","volume":"50","author":"X Jiang","year":"2011","unstructured":"Jiang X, Yi Q, Liu D, Wang S, Li L (2011) A case of juvenile dermatomyositis with severe calcinosis and successful treatment with prednisone and diltiazem. Int J Dermatol 50(1):74\u201377. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04449.x","journal-title":"Int J Dermatol"},{"issue":"3","key":"3148_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1093\/rheumatology\/39.3.333","volume":"39","author":"CS Vinen","year":"2000","unstructured":"Vinen CS, Patel S, Bruckner FE (2000) Regression of calcinosis associated with adult dermatomyositis following diltiazem therapy. Rheumatology 39(3):333\u2013334. https:\/\/doi.org\/10.1093\/rheumatology\/39.3.333","journal-title":"Rheumatology"},{"issue":"2","key":"3148_CR40","first-page":"102","volume":"15","author":"M Abdallah-Lotf","year":"2005","unstructured":"Abdallah-Lotf M, Grasland A, Vinceneux P, Sigal-Grinberg M (2005) Regression of cutis calcinosis with diltiazem in adult dermatomyositis. Eur J Dermatol 15(2):102\u2013104","journal-title":"Eur J Dermatol"},{"issue":"2","key":"3148_CR41","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10067-009-1303-z","volume":"29","author":"NL Sharma","year":"2010","unstructured":"Sharma NL, Mahajan VK, Ranjan N, Sharma VC, Gupta M (2010) Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case. Clin Rheumatol 29(2):215\u2013219. https:\/\/doi.org\/10.1007\/s10067-009-1303-z","journal-title":"Clin Rheumatol"},{"issue":"12","key":"3148_CR42","first-page":"2152","volume":"23","author":"MB Oliveri","year":"1996","unstructured":"Oliveri MB, Palermo R, Mautalen C, H\u00fcbscher O (1996) Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 23(12):2152\u20132155","journal-title":"J Rheumatol"},{"issue":"5","key":"3148_CR43","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1111\/pde.13217","volume":"34","author":"J Singh","year":"2017","unstructured":"Singh J, Paliwal VK, Bhargava P, Mathur DK (2017) Idiopathic calcinosis Cutis Universalis treated successfully with oral Diltiazem\u2014A Case Report. Pediatr Dermatol 34(5):e241\u2013e244. https:\/\/doi.org\/10.1111\/pde.13217","journal-title":"Pediatr Dermatol"},{"key":"3148_CR44","unstructured":"Talreja O, Cassagnol M (2023) Diltiazem. In: StatPearls. StatPearls Publishing; Accessed October 26, 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532937\/"},{"issue":"11","key":"3148_CR45","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.jdcr.2019.08.011","volume":"5","author":"M Tajalli","year":"2019","unstructured":"Tajalli M, Qureshi AA (2019) Successful treatment of calcinosis cutis of fingertip in the setting of CREST syndrome with topical 20% sodium thiosulfate. JAAD Case Rep 5(11):988\u2013990. https:\/\/doi.org\/10.1016\/j.jdcr.2019.08.011","journal-title":"JAAD Case Rep"},{"issue":"3","key":"3148_CR46","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1016\/j.jaad.2013.03.022","volume":"69","author":"GP Smith","year":"2013","unstructured":"Smith GP (2013) Intradermal sodium thiosulfate for exophytic calcinosis cutis of connective tissue disease. J Am Acad Dermatol 69(3):e146\u2013147. https:\/\/doi.org\/10.1016\/j.jaad.2013.03.022","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3148_CR47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.semarthrit.2017.05.013","volume":"47","author":"J Goossens","year":"2017","unstructured":"Goossens J, Courbebaisse M, Caudron E et al (2017) Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: two cases. Semin Arthritis Rheum 47(3):451\u2013455. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.05.013","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"3148_CR48","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1001\/archderm.144.12.1560","volume":"144","author":"EK Wolf","year":"2008","unstructured":"Wolf EK, Smidt AC, Laumann AE (2008) Topical Sodium Thiosulfate Therapy for Leg Ulcers with Dystrophic Calcification. Arch Dermatol 144(12):1560\u20131562. https:\/\/doi.org\/10.1001\/archderm.144.12.1560","journal-title":"Arch Dermatol"},{"key":"3148_CR49","doi-asserted-by":"publisher","unstructured":"Ricardo JW, Sun HY, Gorji M, Sebaratnam DF (2021) Topical sodium thiosulfate as treatment of calcinosis cutis: Case series and systematic review. J Am Acad Dermatol 0(0). https:\/\/doi.org\/10.1016\/j.jaad.2021.09.013","DOI":"10.1016\/j.jaad.2021.09.013"},{"issue":"9","key":"3148_CR50","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1001\/jamadermatol.2017.0966","volume":"153","author":"NS Gunasekera","year":"2017","unstructured":"Gunasekera NS, Maniar LEG, Lezcano C, Laga AC, Merola JF (2017) Intralesional Sodium Thiosulfate Treatment for Calcinosis Cutis in the setting of Lupus Panniculitis. JAMA Dermatology 153(9):944\u2013945. https:\/\/doi.org\/10.1001\/jamadermatol.2017.0966","journal-title":"JAMA Dermatology"},{"issue":"3","key":"3148_CR51","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/bjd.14412","volume":"175","author":"P del Barrio-D\u00edaz","year":"2016","unstructured":"del Barrio-D\u00edaz P, Moll-Manzur C, \u00c1lvarez-Veliz S, Vera-Kellet C (2016) Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy. Br J Dermatol 175(3):608\u2013611. https:\/\/doi.org\/10.1111\/bjd.14412","journal-title":"Br J Dermatol"},{"issue":"6","key":"3148_CR52","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1111\/bjd.15783","volume":"178","author":"P Song","year":"2018","unstructured":"Song P, Fett Nm, Lin J, Merola Jf, Costner M, Vleugels R (2018) a. lack of response to intravenous sodium thiosulfate in three cases of extensive connective tissue disease-associated calcinosis cutis. Br J Dermatol 178(6):1412\u20131415. https:\/\/doi.org\/10.1111\/bjd.15783","journal-title":"Br J Dermatol"},{"issue":"5","key":"3148_CR53","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jaad.2020.06.996","volume":"83","author":"RM Howard","year":"2020","unstructured":"Howard RM, Smith GP (2020) Treatment of calcinosis cutis with sodium thiosulfate therapy. J Am Acad Dermatol 83(5):1518\u20131520. https:\/\/doi.org\/10.1016\/j.jaad.2020.06.996","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3148_CR54","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1111\/ced.13782","volume":"44","author":"JE Ma","year":"2019","unstructured":"Ma JE, Ernste FC, Davis MDP, Wetter DA (2019) Topical sodium thiosulfate for calcinosis cutis associated with autoimmune connective tissue diseases: the Mayo Clinic experience, 2012\u20132017. Clin Exp Dermatol 44(5):e189\u2013e192. https:\/\/doi.org\/10.1111\/ced.13782","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"3148_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jdin.2020.07.002","volume":"1","author":"AR Winter","year":"2020","unstructured":"Winter AR, Klager S, Truong R, Foley A, Sami N, Weinstein D (2020) Efficacy of intralesional sodium thiosulfate for the treatment of dystrophic calcinosis cutis: a double-blind, placebo-controlled pilot study. JAAD Int 1(2):114\u2013120. https:\/\/doi.org\/10.1016\/j.jdin.2020.07.002","journal-title":"JAAD Int"},{"issue":"5 Pt 1","key":"3148_CR56","doi-asserted-by":"publisher","first-page":"648","DOI":"10.7326\/0003-4819-89-5-648","volume":"89","author":"J Taborn","year":"1978","unstructured":"Taborn J, Bole GG, Thompson GR (1978) Colchicine suppression of local and systemic inflammation due to calcinosis universalis in chronic dermatomyositis. Ann Intern Med 89(5 Pt 1):648\u2013649. https:\/\/doi.org\/10.7326\/0003-4819-89-5-648","journal-title":"Ann Intern Med"},{"issue":"4","key":"3148_CR57","first-page":"527","volume":"5","author":"D Fuchs","year":"1986","unstructured":"Fuchs D, Fruchter L, Fishel B, Holtzman M, Yaron M (1986) Colchicine suppression of local inflammation due to calcinosis in dermatomyositis and progressive systemic sclerosis. Clin Rheumatol 5(4):527\u2013530","journal-title":"Clin Rheumatol"},{"issue":"8","key":"3148_CR58","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1742-1241.1998.tb08948.x","volume":"52","author":"P Vereecken","year":"1998","unstructured":"Vereecken P, Stallenberg B, Tas S, de Dobbeleer G, Heenen M (1998) Ulcerated dystrophic calcinosis cutis secondary to localised linear scleroderma. Int J Clin Pract 52(8):593\u2013594","journal-title":"Int J Clin Pract"},{"issue":"1","key":"3148_CR59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","volume":"22","author":"S Stewart","year":"2020","unstructured":"Stewart S, Yang KCK, Atkins K, Dalbeth N, Robinson PC (2020) Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials. Arthritis Res Ther 22(1):28. https:\/\/doi.org\/10.1186\/s13075-020-2120-7","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3148_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/ard.62.3.267","volume":"62","author":"LP Robertson","year":"2003","unstructured":"Robertson LP, Marshall RW, Hickling P (2003) Treatment of cutaneous calcinosis in limited systemic sclerosis with minocycline. Ann Rheum Dis 62(3):267\u2013269. https:\/\/doi.org\/10.1136\/ard.62.3.267","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3148_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jaad.2010.08.039","volume":"65","author":"N Reiter","year":"2011","unstructured":"Reiter N, El-Shabrawi L, Leinweber B, Berghold A, Aberer E (2011) Calcinosis cutis: part II. Treatment options. J Am Acad Dermatol 65(1):15\u201322 quiz 23\u201324. https:\/\/doi.org\/10.1016\/j.jaad.2010.08.039","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3148_CR62","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1016\/j.jaad.2009.11.016","volume":"63","author":"N Reiter","year":"2010","unstructured":"Reiter N, El-Shabrawi L, Leinweber B, Aberer E (2010) Subcutaneous morphea with dystrophic calcification with response to ceftriaxone treatment. J Am Acad Dermatol 63(2):e53\u2013e55. https:\/\/doi.org\/10.1016\/j.jaad.2009.11.016","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3148_CR63","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.amjmed.2015.11.032","volume":"129","author":"TJ Poterucha","year":"2016","unstructured":"Poterucha TJ, Goldhaber SZ (2016) Warfarin and vascular calcification. Am J Med 129(6):635. .e1-4","journal-title":"Am J Med"},{"issue":"10","key":"3148_CR64","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1136\/ard.2003.014431","volume":"63","author":"T Cukierman","year":"2004","unstructured":"Cukierman T, Elinav E, Korem M, Chajek-Shaul T (2004) Low dose warfarin treatment for calcinosis in patients with systemic sclerosis. Ann Rheum Dis 63(10):1341\u20131343. https:\/\/doi.org\/10.1136\/ard.2003.014431","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"3148_CR65","first-page":"1233","volume":"20","author":"S Yoshida","year":"1993","unstructured":"Yoshida S, Torikai K (1993) The effects of warfarin on calcinosis in a patient with systemic sclerosis. J Rheumatol 20(7):1233\u20131235","journal-title":"J Rheumatol"},{"issue":"4","key":"3148_CR66","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/0002-9343(88)90128-3","volume":"84","author":"K Lassoued","year":"1988","unstructured":"Lassoued K, Saiag P, Anglade MC, Roujeau JC, Touraine RL (1988) Failure of warfarin in treatment of calcinosis universalis. Am J Med 84(4):795\u2013796. https:\/\/doi.org\/10.1016\/0002-9343(88)90128-3","journal-title":"Am J Med"},{"issue":"24","key":"3148_CR67","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1056\/NEJM197412122912408","volume":"291","author":"AL Metzger","year":"1974","unstructured":"Metzger AL, Singer FR, Bluestone R, Pearson CM (1974) Failure of Disodium Etidronate in Calcinosis due to Dermatomyositis and Scleroderma. N Engl J Med 291(24):1294\u20131296. https:\/\/doi.org\/10.1056\/NEJM197412122912408","journal-title":"N Engl J Med"},{"issue":"3","key":"3148_CR68","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/archderm.1975.01630150077009","volume":"111","author":"SF Rabens","year":"1975","unstructured":"Rabens SF, Bethune JE (1975) Disodium etidronate therapy for Dystrophic cutaneous calcification. Arch Dermatol 111(3):357\u2013361. https:\/\/doi.org\/10.1001\/archderm.1975.01630150077009","journal-title":"Arch Dermatol"},{"issue":"1","key":"3148_CR69","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00774-011-0289-1","volume":"30","author":"H Mori","year":"2012","unstructured":"Mori H, Okada Y, Yamaoka K, Saito K, Tanaka Y (2012) Marked improvement of calcinosis in adult dermatomyositis with etidronate therapy. J Bone Min Metab 30(1):114\u2013118. https:\/\/doi.org\/10.1007\/s00774-011-0289-1","journal-title":"J Bone Min Metab"},{"issue":"5","key":"3148_CR70","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1067\/mpd.2001.112473","volume":"138","author":"M Mukamel","year":"2001","unstructured":"Mukamel M, Horev G, Mimouni M (2001) New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 138(5):763\u2013766. https:\/\/doi.org\/10.1067\/mpd.2001.112473","journal-title":"J Pediatr"},{"issue":"9","key":"3148_CR71","first-page":"1837","volume":"32","author":"GR Ambler","year":"2005","unstructured":"Ambler GR, Chaitow J, Rogers M, McDonald DW, Ouvrier RA (2005) Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy. J Rhuematol 32(9):1837\u20131839","journal-title":"J Rhuematol"},{"issue":"1","key":"3148_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41927-021-00176-5","volume":"5","author":"M Platter","year":"2021","unstructured":"Platter M, Pugmire B, Patel R (2021) Resolution of calcinosis using bisphosphonates in overlap syndrome - a case report. BMC Rheumatol 5(1):6. https:\/\/doi.org\/10.1186\/s41927-021-00176-5","journal-title":"BMC Rheumatol"},{"issue":"5","key":"3148_CR73","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/RHU.0000000000000264","volume":"21","author":"CA Ca\u00f1as","year":"2015","unstructured":"Ca\u00f1as CA, Bonilla-Abad\u00eda F, Mej\u00eda M, Tob\u00f3n GJ (2015) Recovery of severe muscular and fascial calcinosis after treatment with bisphosphonates in a child with Juvenile Dermatomyositis. J Clin Rheumatol 21(5):267\u2013269. https:\/\/doi.org\/10.1097\/RHU.0000000000000264","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"3148_CR74","first-page":"135","volume":"28","author":"A Marco Puche","year":"2010","unstructured":"Marco Puche A, Calvo Penades I, Lopez Montesinos B (2010) Effectiveness of the treatment with intravenous pamidronate in calcinosis in juvenile dermatomyositis. Clin Exp Rheumatol 28(1):135\u2013140","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"3148_CR75","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/RHU.0000000000000199","volume":"20","author":"P Palaniappan","year":"2014","unstructured":"Palaniappan P, Lionel AP, Kumar S (2014) Successful treatment of Calcinosis Cutis in Juvenile Dermatomyositis with Pamidronate. JCR: J Clin Rheumatol 20(8):454\u2013455. https:\/\/doi.org\/10.1097\/RHU.0000000000000199","journal-title":"JCR: J Clin Rheumatol"},{"issue":"1","key":"3148_CR76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00247-013-2738-6","volume":"44","author":"J Martillotti","year":"2014","unstructured":"Martillotti J, Moote D, Zemel L (2014) Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis. Pediatr Radiol 44(1):115\u2013118. https:\/\/doi.org\/10.1007\/s00247-013-2738-6","journal-title":"Pediatr Radiol"},{"issue":"1","key":"3148_CR77","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","volume":"77","author":"S Slimani","year":"2010","unstructured":"Slimani S, Abdessemed A, Haddouche A, Ladjouze-Rezig A (2010) Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate. Joint Bone Spine 77(1):70\u201372. https:\/\/doi.org\/10.1016\/j.jbspin.2009.04.011","journal-title":"Joint Bone Spine"},{"issue":"11","key":"3148_CR78","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.3390\/biomedicines9111698","volume":"9","author":"L Rauch","year":"2021","unstructured":"Rauch L, Hein R, Biedermann T, Eyerich K, Lauffer F (2021) Bisphosphonates for the treatment of Calcinosis Cutis\u2014A retrospective single-center study. Biomedicines 9(11):1698. https:\/\/doi.org\/10.3390\/biomedicines9111698","journal-title":"Biomedicines"},{"issue":"4","key":"3148_CR79","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1440-0960.1997.tb01698.x","volume":"38","author":"S Wananukul","year":"1997","unstructured":"Wananukul S, Pongprasit P, Wattanakrai P (1997) Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: report of two cases. Australas J Dermatol 38(4):202\u2013205. https:\/\/doi.org\/10.1111\/j.1440-0960.1997.tb01698.x","journal-title":"Australas J Dermatol"},{"issue":"11","key":"3148_CR80","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1001\/archderm.1988.01670110077022","volume":"124","author":"WJ Wang","year":"1988","unstructured":"Wang WJ, Lo WL, Wong CK (1988) Calcinosis Cutis in Juvenile Dermatomyositis: remarkable response to Aluminum Hydroxide Therapy. Arch Dermatol 124(11):1721\u20131722. https:\/\/doi.org\/10.1001\/archderm.1988.01670110077022","journal-title":"Arch Dermatol"},{"issue":"5","key":"3148_CR81","first-page":"879","volume":"34","author":"Y Aihara","year":"1994","unstructured":"Aihara Y, Mori M, Ibe M et al (1994) [A case of juvenile dermatomyositis with calcinosis universalis\u2013remarkable improvement with aluminum hydroxide therapy]. Ryumachi 34(5):879\u2013884","journal-title":"Ryumachi"},{"issue":"9","key":"3148_CR82","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1346-8138.1993.tb01338.x","volume":"20","author":"T Nakagawa","year":"1993","unstructured":"Nakagawa T, Takaiwa T (1993) Calcinosis Cutis in Juvenile Dermatomyositis Responsive to Aluminum Hydroxide Treatment. J Dermatol 20(9):558\u2013560. https:\/\/doi.org\/10.1111\/j.1346-8138.1993.tb01338.x","journal-title":"J Dermatol"},{"issue":"239","key":"3148_CR83","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1136\/adc.45.239.118","volume":"45","author":"JR Nassim","year":"1970","unstructured":"Nassim JR, Connolly CK (1970) Treatment of calcinosis Universalis with Aluminium Hydroxide. Arch Dis Child 45(239):118\u2013121","journal-title":"Arch Dis Child"},{"issue":"5","key":"3148_CR84","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3346\/jkms.1999.14.5.589","volume":"14","author":"YM Park","year":"2009","unstructured":"Park YM, Lee SJ, Kang H, Cho SH (2009) Large subcutaneous calcification in systemic lupus erythematosus: treatment with oral aluminum hydroxide administration followed by surgical excision. J Korean Med Sci 14(5):589\u2013592. https:\/\/doi.org\/10.3346\/jkms.1999.14.5.589","journal-title":"J Korean Med Sci"},{"key":"3148_CR85","doi-asserted-by":"publisher","unstructured":"Hudson PM, Jones PE, Robinson TWE, Dent CE (1974) Extensive Calcinosis with Minimal Scleroderma: Treatment of Ectopic Calcification with Aluminum Hydroxide. Proceedings of the Royal Society of Medicine. ;67(11):1166\u20131168. https:\/\/doi.org\/10.1177\/003591577406701130","DOI":"10.1177\/003591577406701130"},{"key":"3148_CR86","unstructured":"Shon NN, Yarbrough T, Patel P (2023) Aluminum Hydroxide. In: StatPearls. StatPearls Publishing; Accessed October 26, 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK546669\/"},{"key":"3148_CR87","doi-asserted-by":"publisher","first-page":"276393","DOI":"10.4061\/2011\/276393","volume":"2011","author":"M Kawahara","year":"2011","unstructured":"Kawahara M, Kato-Negishi M (2011) Link between aluminum and the pathogenesis of Alzheimer\u2019s Disease: the integration of the aluminum and amyloid Cascade hypotheses. Int J Alzheimers Dis 2011:276393. https:\/\/doi.org\/10.4061\/2011\/276393","journal-title":"Int J Alzheimers Dis"},{"issue":"11","key":"3148_CR88","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1210\/jcem.82.11.4343","volume":"82","author":"MC Eddy","year":"1997","unstructured":"Eddy MC, Leelawattana R, McAlister WH, Whyte MP (1997) Calcinosis universalis complicating juvenile dermatomyositis: resolution during probenecid therapy. J Clin Endocrinol Metab 82(11):3536\u20133542. https:\/\/doi.org\/10.1210\/jcem.82.11.4343","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"3148_CR89","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1529-8019.2012.01492.x","volume":"25","author":"A Gutierrez Jr","year":"2012","unstructured":"Gutierrez A Jr, Wetter DA (2012) Calcinosis cutis in autoimmune connective tissue diseases. Dermatol Ther 25(2):195\u2013206. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01492.x","journal-title":"Dermatol Ther"},{"issue":"2","key":"3148_CR90","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/03009748109095279","volume":"10","author":"E Skuterud","year":"1981","unstructured":"Skuterud E, Sydnes OA, Haavik TK (1981) Calcinosis in Dermatomyositis Treated with Probenecid. Scand J Rheumatol 10(2):92\u201394. https:\/\/doi.org\/10.3109\/03009748109095279","journal-title":"Scand J Rheumatol"},{"issue":"8","key":"3148_CR91","first-page":"1691","volume":"33","author":"H Nakamura","year":"2006","unstructured":"Nakamura H, Kawakami A, Ida H, Ejima E, Origuchi T, Eguchi K (2006) Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis. J Rhuematol 33(8):1691\u20131693","journal-title":"J Rhuematol"},{"issue":"5","key":"3148_CR92","first-page":"1129","volume":"28","author":"L Harel","year":"2001","unstructured":"Harel L, Harel G, Korenreich L, Straussberg R, Amir J (2001) Treatment of calcinosis in juvenile dermatomyositis with probenecid: the role of phosphorus metabolism in the development of calcifications. J Rhuematol 28(5):1129\u20131132","journal-title":"J Rhuematol"},{"issue":"7","key":"3148_CR93","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1001\/archderm.1978.01640190064023","volume":"114","author":"SS Lee","year":"1978","unstructured":"Lee SS, Felsenstein J, Tanzer FR (1978) Calcinosis Cutis Circumscripta: treatment with an Intralesional Corticosteroid. Arch Dermatol 114(7):1080\u20131081. https:\/\/doi.org\/10.1001\/archderm.1978.01640190064023","journal-title":"Arch Dermatol"},{"issue":"5","key":"3148_CR94","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1001\/archderm.1982.01650170080035","volume":"118","author":"PG Hazen","year":"1982","unstructured":"Hazen PG, Walker AE, Carney JF, Stewart JJ (1982) Cutaneous calcinosis of Scleroderma: successful treatment with Intralesional adrenal steroids. Arch Dermatol 118(5):366\u2013367. https:\/\/doi.org\/10.1001\/archderm.1982.01650170080035","journal-title":"Arch Dermatol"},{"key":"3148_CR95","unstructured":"Zare P, Heller D (2023) Treprostinil. In: StatPearls. StatPearls Publishing; Accessed November 1, 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545152\/"},{"issue":"6","key":"3148_CR96","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/rheumatology\/keab810","volume":"61","author":"MP Chung","year":"2022","unstructured":"Chung MP, Valenzuela A, Li S et al (2022) A pilot study to evaluate the safety and efficacy of treprostinil in the treatment of calcinosis in systemic sclerosis. Rheumatology 61(6):2441\u20132449. https:\/\/doi.org\/10.1093\/rheumatology\/keab810","journal-title":"Rheumatology"},{"issue":"2","key":"3148_CR97","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s10067-004-1023-3","volume":"24","author":"AY Chan","year":"2005","unstructured":"Chan AY, Li E (2005) Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis\u2014old method, new discovery. Clin Rheumatol 24(2):172\u2013173. https:\/\/doi.org\/10.1007\/s10067-004-1023-3","journal-title":"Clin Rheumatol"},{"issue":"5","key":"3148_CR98","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1016\/j.jaad.2005.04.010","volume":"53","author":"A Sparsa","year":"2005","unstructured":"Sparsa A, Lesaux N, Kessler E et al (2005) Treatment of cutaneous calcinosis in CREST syndrome by extracorporeal shock wave lithotripsy. J Am Acad Dermatol 53(5):S263\u2013S265. https:\/\/doi.org\/10.1016\/j.jaad.2005.04.010","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"3148_CR99","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1111\/ced.14857","volume":"46","author":"P Beatty","year":"2021","unstructured":"Beatty P, Killion L, Power R, Roche M (2021) Dystrophic calcinosis cutis successfully treated with extracorporeal shockwave lithotripsy. Clin Exp Dermatol 46(8):1656\u20131658. https:\/\/doi.org\/10.1111\/ced.14857","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"3148_CR100","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jaad.2010.12.035","volume":"66","author":"N Sultan-Bichat","year":"2012","unstructured":"Sultan-Bichat N, Menard J, Perceau G, Staerman F, Bernard P, Reguia\u00ef Z (2012) Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy. J Am Acad Dermatol 66(3):424\u2013429. https:\/\/doi.org\/10.1016\/j.jaad.2010.12.035","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl 100","key":"3148_CR101","first-page":"177","volume":"34","author":"S Blumhardt","year":"2016","unstructured":"Blumhardt S, Frey DP, Toniolo M, Alkadhi H, Held U, Distler O (2016) Safety and efficacy of extracorporeal shock wave therapy (ESWT) in calcinosis cutis associated with systemic sclerosis. Clin Exp Rheumatol 34(Suppl 100):177\u2013180","journal-title":"Clin Exp Rheumatol"},{"key":"3148_CR102","doi-asserted-by":"publisher","unstructured":"Bottomley Ww, Goodfield M (1996) j. d., Sheehan-Dare R a. Digital calcification in systemic sclerosis: effective treatment with good tissue preservation using the carbon dioxide laser. British Journal of Dermatology. ;135(2):302\u2013304. https:\/\/doi.org\/10.1111\/j.1365-2133.1996.tb01166.x","DOI":"10.1111\/j.1365-2133.1996.tb01166.x"},{"issue":"9","key":"3148_CR103","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1046\/j.1524-4725.2003.29261.x","volume":"29","author":"AJ Chamberlain","year":"2003","unstructured":"Chamberlain AJ, Walker NPJ (2003) Successful palliation and significant remission of cutaneous calcinosis in CREST Syndrome with Carbon Dioxide laser. Dermatol Surg 29(9):968\u2013970. https:\/\/doi.org\/10.1046\/j.1524-4725.2003.29261.x","journal-title":"Dermatol Surg"},{"issue":"9","key":"3148_CR104","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jdcr.2020.06.022","volume":"6","author":"M Abrouk","year":"2020","unstructured":"Abrouk M, Nousari Y, Waibel JS (2020) Novel treatment of calcifications from dermatomyositis with picosecond and carbon dioxide laser. JAAD Case Rep 6(9):852\u2013853. https:\/\/doi.org\/10.1016\/j.jdcr.2020.06.022","journal-title":"JAAD Case Rep"},{"issue":"5","key":"3148_CR105","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1524-4725.2010.01539.x","volume":"36","author":"M Meissner","year":"2010","unstructured":"Meissner M, Ochsendorf F, Kaufmann R, Letter (2010) Therapy of Calcinosis Cutis using erbium-doped Yttrium Aluminum Garnet Laser Treatment. Dermatol Surg 36(5):727\u2013728. https:\/\/doi.org\/10.1111\/j.1524-4725.2010.01539.x","journal-title":"Dermatol Surg"},{"issue":"2","key":"3148_CR106","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/archderm.145.2.212-b","volume":"145","author":"N Saddic","year":"2009","unstructured":"Saddic N, Miller JJ, Miller OF III, Clarke JT (2009) Surgical debridement of painful fingertip calcinosis Cutis in CREST Syndrome. Arch Dermatol 145(2):212\u2013213. https:\/\/doi.org\/10.1001\/archderm.145.2.212-b","journal-title":"Arch Dermatol"},{"issue":"3","key":"3148_CR107","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/art.1780400325","volume":"40","author":"MAM Cousins","year":"1997","unstructured":"Cousins MAM, Jones DB, Whyte MP, Monafo WW (1997) Surgical management of calcinosis cutis universalis in systemic lupus erythematosus. Arthr Rhuem 40(3):570\u2013572. https:\/\/doi.org\/10.1002\/art.1780400325","journal-title":"Arthr Rhuem"},{"issue":"5","key":"3148_CR108","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1097\/BPO.0000000000000358","volume":"35","author":"MC Welborn","year":"2015","unstructured":"Welborn MC, Gottschalk H, Bindra R, Juvenile Dermatomyositis (2015) A case of Calcinosis Cutis of the elbow and review of the literature. J Pediatr Orthop 35(5):e43\u201346. https:\/\/doi.org\/10.1097\/BPO.0000000000000358","journal-title":"J Pediatr Orthop"},{"issue":"5","key":"3148_CR109","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/0266-7681(94)90134-1","volume":"19","author":"A Minami","year":"1994","unstructured":"Minami A, Suda K, Kaneda K, Kumakiri M (1994) Extensive subcutaneous calcification of the forearm in systemic lupus erythematosus. J Hand Surg Br 19(5):638\u2013641. https:\/\/doi.org\/10.1016\/0266-7681(94)90134-1","journal-title":"J Hand Surg Br"},{"issue":"4","key":"3148_CR110","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1524-4725.2007.34106.x","volume":"34","author":"JJ Wu","year":"2008","unstructured":"Wu JJ, Metz BJ (2008) Calcinosis cutis of juvenile dermatomyositis treated with incision and drainage. Dermatol Surg 34(4):575\u2013577. https:\/\/doi.org\/10.1111\/j.1524-4725.2007.34106.x","journal-title":"Dermatol Surg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03148-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03148-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03148-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T20:32:19Z","timestamp":1725913939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03148-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":110,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3148"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03148-0","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"12 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Charles B. Lau: Conceptualization, investigation, writing, original draft, review and editing. Gideon P. Smith: Conceptualization, investigation, writing, review and editing. We declare no conflict of interest and no funding sources.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors contribution statement"}}],"article-number":"390"}}